Rutgers Researchers Call for Balanced Approach to E-Cigarette Use

Jul.25.2022
Rutgers experts urge balanced approach to examining latest trends in adult e-cigarette use, citing potential benefits and health concerns.

Researchers from Rutgers University are urging for a balanced approach to reviewing the latest trends in adult electronic cigarette use.


Assistant Professor Julia Chen-Sankey and Lecturer Michelle T of the Department of Health Behavior, Society, and Policy at Rutgers School of Public Health, along with Lecturer Bover-Manderski of the Department of Biostatistics and Epidemiology at Rutgers, suggest that while there are clear health concerns associated with using e-cigarettes, particularly among those who have not previously used tobacco products, there are also potential benefits that should not be overlooked.


Researchers at Rutgers University have published an invited commentary in the Journal of the American Medical Association (JAMA) Network Open, reviewing new data on the trend of electronic cigarette use among American adults. The researchers, Chen-Sankey and Bover-Manderski, are also members of the Rutgers Tobacco Studies Center. They discuss the necessity of public health approaches to achieve a balance between risks and potential of electronic cigarettes in promoting smoking cessation among adults who currently use combustible cigarettes.


This study raises important questions about the use of electronic cigarettes by adults in the United States. What did the study find and what questions does it pose for public health policy?


Chen-Sankey's research paper explores the latest trends in electronic cigarette use among adults in the United States in 2017, 2018, and 2020. One of the key findings is that while the use of e-cigarettes among young adults aged 18 to 20 has decreased from 2018 to 2020, it has increased among other age groups. Additionally, there has been an increase in the frequency of daily e-cigarette use among current users.


Perhaps the most shocking revelation is that the usage of e-cigarettes among those who have never smoked combustible cigarettes has significantly increased. While e-cigarettes may have the potential to aid in smoking cessation, there has also been a decrease in the number of traditional smokers attempting to quit.


Bover-Manderski: How can these contradictory findings be applied to health policies? It is important to strike a balance between new teenage users and older smokers who want to quit.


Question: How do we strike this balance?


Chen-Sankey suggests that certain policy developments and strategies could ensure the public health benefits of using e-cigarettes. For instance, the recent authorization of e-cigarette products in the United States. The Food and Drug Administration (FDA) through its PMTA review could help establish public trust in authorized e-cigarette products.


Bover-Manderski stated that in order to increase the acceptance of traditional smokers using e-cigarettes as a means to quit smoking, public health education and mass media dissemination strategies should focus on promoting the evidence-based results of e-cigarettes harm reduction.


Question: Why do some traditional adult smokers refuse to use e-cigarettes as a method to quit smoking?


Chen-Sankey stated that in the past five years, the appeal of e-cigarette products for traditional smokers interested in quitting has decreased, but they have become more attractive to non-smokers. Several factors can help explain this frustrating pattern.


Firstly, policies aimed at reducing youth use of electronic cigarettes may also decrease interest and use among adult smokers attempting to quit. Additionally, media coverage may be shaping smokers' understanding of e-cigarettes as the amount of reporting on the risks for youth using e-cigarettes outweighs the potential benefits for adult combustible cigarette users.


Bover-Manderski suggests that public health organizations and healthcare professionals may need to shift their focus from the potential benefits of using combustible tobacco products among adults, to the risks associated with young people using e-cigarettes.


Question: One highlight of this study was a significant decrease in the proportion of young people aged 18 to 20 who use e-cigarettes. What explains this decrease?


Chen-Sankey suggests that this discrepancy may be related to the Tobacco Act, which limits the sale of tobacco and nicotine products, including e-cigarettes, to this age group starting in January 2020. Another potential explanation is the national restrictions implemented in February 2020 on certain flavored e-cigarettes, which may have significantly reduced their appeal among young people.


Bover-Manderski stated that it is important to acknowledge the impact of COVID-19-related lockdowns and social distancing requirements, which may restrict opportunities for this demographic to use e-cigarettes in social or group settings.


I'm sorry, but I do not have context or any text to translate to standard journalistic English. Please provide more information.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
South Korea Constitutional Court Upholds Volume-Based E-Liquid Tax, With Challenged Rates at KRW 370 and KRW 628 per Milliliter
South Korea Constitutional Court Upholds Volume-Based E-Liquid Tax, With Challenged Rates at KRW 370 and KRW 628 per Milliliter
South Korea's Constitutional Court has upheld fixed taxes on nicotine-containing e-cigarette liquids based on solution volume, ruling that challenged provisions imposing KRW 370 per milliliter in individual consumption tax and KRW 628 per milliliter in tobacco consumption tax do not violate the Constitution. The cases stemmed from historical disputes involving importers that reported nicotine as being extracted from tobacco stems rather than leaves. South Korea has since broadened its tobacco definition to include synthetic nicotine, while current tax laws provide reduced rates for certain products not derived from tobacco.
Sep.18
From Product Innovation to Integrated Solutions: NEXTECH Expands Its Global Heated Tobacco Solutions
From Product Innovation to Integrated Solutions: NEXTECH Expands Its Global Heated Tobacco Solutions
NEXTECH launched its NEXE Pro circumferential-heating tobacco stick globally at InterTabac 2026, as the company expands from product innovation into broader heated tobacco solutions. Amid intensifying competition across global HTP markets, NEXTECH is strengthening its R&D, manufacturing and pre-launch support capabilities to serve different types of business customers.
Industry Insight
Sep.15
Canada Health Minister Says She Is Not Considering Looser Nicotine Pouch Retail Rules as PMI-Linked Group Pushes for Wider Access
Canada Health Minister Says She Is Not Considering Looser Nicotine Pouch Retail Rules as PMI-Linked Group Pushes for Wider Access
Canadian Health Minister Marjorie Michel says she is not considering loosening retail restrictions on nicotine pouches. Canada regulates pouches containing 4 mg or less of nicotine per unit as non-prescription nicotine replacement therapy and requires newer NRT formats such as pouches to be sold from behind pharmacy counters. Meanwhile, Unsmoke Canada, linked to Philip Morris International's Canadian business, is pushing to allow pouches in convenience stores and other general retail outlets. Health Canada also acknowledges continued unauthorized sales, while recent research shows rising pouch use among Canadian youth aged 16 to 19.
Sep.24
Malaysia Liquid Nicotine Returns to Poisons List, Leaving Vape Retail and RM354 Million Tax Collection in Legal Uncertainty
Malaysia Liquid Nicotine Returns to Poisons List, Leaving Vape Retail and RM354 Million Tax Collection in Legal Uncertainty
Malaysia’s withdrawal of its appeal in a landmark liquid-nicotine case has left a High Court ruling that struck down the 2023 nicotine exemption in force, bringing liquid and gel nicotine used in vaping products back under the Poisons Act 1952. At the same time, the Control of Smoking Products for Public Health Act 2024 continues to provide a regulatory framework for vaping products, creating uncertainty over retail sales, taxation and existing inventory. MPs are calling for nicotine vape sales and excise collection to stop, including refunds of more than RM354 million collected since 2023, while industry and consumer groups are asking the government to clarify the current legal position.
Sep.04
Product | DOJO Launches BLAST10K Fresh in UK With 0+10ml E-Liquid Structure, Retaining 2+8ml Pod Compatibility
Product | DOJO Launches BLAST10K Fresh in UK With 0+10ml E-Liquid Structure, Retaining 2+8ml Pod Compatibility
DOJO launched the BLAST10K Fresh in the UK on September 4, 2026, introducing its INSTA-JUICED™ technology and a new 0+10ml structure that keeps e-liquid separated from the coil before activation. The device features a 1000mAh rechargeable battery, COREX BLAST dual-mesh technology and SSS leak-resistant technology, with a manufacturer-rated capacity of up to 10,000 puffs. It also retains compatibility with existing 2+8ml pods across the BLAST ecosystem. The launch introduces eight new flavors, including Matcha Strawberry, which DOJO describes as an industry first.
Market
Sep.04